El Dr. Alejandro Ferreiro Fuentes se graduó de la Facultad de Medicina de la Universidad de la República de Uruguay en el año 1991. Completó la Residencia de medicina Interna en 1994, el posgrado en nefrología en 1997 y el posgrado en gestión de servicios de salud en 2011. Es docente del Centro de Nefrología, Facultad de Medicina (Universidad de la República) desde 1997, ocupando actualmente el cargo de Profesor Agregado (grado 4), e integra el Sistema Nacional de Investigadores (SNI-ANII). Las áreas de investigación se centran principalmente en: 1) Epidemiología y planificación asistencial para todas las etapas de la ERC y sus complicaciones. 2) Lesión renal aguda: prevención, epidemiología, resultados clínicos y a largo plazo. La producción científica ha sido publicada en libros, artículos de revisión, informes o artículos científicos completos en revistas indexadas regionales y extra regionales. Fue presidente de la Sociedad Uruguaya de Nefrología (2016-2018). Actualmente es Presidente de la Sociedad Latinoamericana de Nefrología e Hipertensión (SLANH).
Nutricionista formada pela USP de Ribeirão Preto em 2008, especializada em Nutrição e Dietética em Nefrologia pela Universidade de Pisa (Itália) em 2013, mestre em Ciência da Alimentação e Nutrição Humana pela Universidade de Milão em 2016, atualmente doutoranda pelo instituto NUTRIM da Universidade de Maastricht (Holanda) como estudante de PhD externo. Nutricionista renal e pesquisadora no Hospital universitário de Parma (Itália) desde 2015 Membro do board do European Renal Nutrition Working Group da sociedade ERA-EDTA desde 2021 Membro do working group pro novo ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease Autora do módulo sobre Nutrição em Hemodiálise pro programa Life Long Learning (LLL) da sociedade ESPEN
Nutricionista formada pela Pontifícia Universidade Católica de Campinas. Fez Especialização em Nutrição e Doenças Renais, Mestrado e Doutorado em Ciências na Universidade Federal de São Paulo e Pós-Doutorado no Instituto Karolinska (Suécia). Atualmente é Docente do Programa de Pós-Graduação em Alimentação, Nutrição e Saúde do Instituto de Nutrição da Universidade do Estado de São Paulo e, Pesquisadora e líder de Pesquisa em Nutrição do Department of Clinical Science Intervention and Technology, Nephrology Division, Baxter Novum do Karolinska Institutet (Suécia). Seu maior interesse é em pesquisa clínica sobre aspectos nutricionais na doença renal crônica com ênfase em avaliação nutricional, avaliação de composição, avaliação de padrão alimentar e intervenções nutricionais de dieta "plant-based".
Christian Faul received his undergraduate training in biology at the Ruprecht Karls University Heidelberg in Germany. He earned his PhD in cell biology at the Albert Einstein College of Medicine in the U.S., and he currently holds the rank of Associate Professor in the Division of Nephrology at the University of Alabama at Birmingham. Dr. Faul has a strong interest in translational medicine, especially in pathomechanisms underlying diseases of the kidney and the heart. His basic research focuses on fibroblast growth factors 23 (FGF23) and phosphate and their pathological effects on the heart, liver, and skeletal muscle in the context of chronic kidney disease (CKD). Dr. Faul’s group was the first to show that FGF23 can have klotho-independent effects on specific cell types and thereby contributes cardiac hypertrophy and systemic inflammation. He currently analyzes beneficial effects of pharmacological inhibitors for FGF receptors and phosphate transporters in animal models with CKD.
Christopher Chan graduated from the Faculty of Medicine, University of Toronto in 1995. After completing his post-graduate training in internal medicine and nephrology at the University of Toronto, he pursued further training in cardiovascular physiology. He joined the Division of Nephrology at the Toronto General Hospital, University Health Network in 2002. He is presently Director of the Division of Nephrology, Professor of Medicine and holds the R Fraser Elliott Chair in Home Dialysis. Dr. Chan is also the Deputy Physician in Chief of Economics at the University Health Network. He also serves as Associate Editor for the Clinical Journal of the American Society of Nephrology.
He has contributed over 200 peer-reviewed articles and has written multiple book chapters in the field of home dialysis. His current research interests include the clinical, genomic physiological changes of intensive hemodialysis, cardiovascular disease in chronic kidney disease and sleep disorders in patients with end-stage renal disease. He has championed and defined clinical use of home dialysis, leading and coordinating a large network dedicated to the clinical and basic science aspects of optimal dialysis delivery. Dr. Chan have received multiple awards and was recently honored by Temetry Faculty of Medicine 2020 Dean’s Award for his leadership and impact on renal replacement therapy. (Honouring Impact: The 2020 Dean’s Alumni Awards | Faculty of Medicine (utoronto.ca))
Professor na Escola Superior de Enfermagem do Porto. Doutorado em Ciências da Enfermagem Universidade Porto. Investigador no CINTESIS. Perito em acesso vascular, formação complementar em ultrassom na Universidade Autónoma Barcelona
Dr. Cristian V. Riella is a physician-scientist and educator at Beth Israel Deaconess Medical Center and Instructor in Medicine at Harvard Medical School. He completed his Internal Medicine residency at St. Elizabeth’s Medical Center, Tufts School of Medicine, and his Nephrology fellowship at Beth Israel Deaconess Medical Center. Dr. Riella’s research focuses on genetic causes of kidney diseases, particularly polycystic kidney disease and Apolipoprotein L1 nephropathy. He is also investigating how RNA editing modulates gene expression in kidney disease via innate immune activation. He is involved in clinical trials testing novel therapies for autosomal dominant polycystic kidney diseases. Dr. Riella is an active educator teaching at the practice of medicine course for Harvard Medical School and point-of-care ultrasound for residents and fellows at BIDMC. Dr. Riella has published numerous papers, chapters including a textbook in PKD aimed at scientists and physicians. He is currently funded by the National Kidney Foundation.
Denis Fouque, MD, PhD, is Professor of Nephrology at the University Claude Bernard Lyon1, and Chief of the Division of Nephrology at Lyon Sud Hospital in Lyon, France. Dr Fouque has published 410 papers, including reviews, meta-analyses and 25 book chapters. He received more than 24,000 citations. His research fields are in nutrition and metabolism in chronic kidney disease and dialysis. He was director of adipocyte dysfunction research group in INSERM 1060 Unit at the University Claude Bernard Lyon1. Dr Fouque got training in Evidence based Medicine by founding the Cochrane Collaboration Renal Group in 1997 and being the Co-ordinating Editor until 2001. Dr Fouque was President of the International Society for Renal Nutrition and Metabolism (2004–2006), Editor-in-Chief of the Journal of Renal Nutrition (2003-2010) and chairman of the ERA-EDTA Nutrition Guideline (2007). Dr Fouque is past Research vice-president at the University Claude Bernard Lyon, vice-chairman of the European Renal Best Practice group of ERA-EDTA and a member of the K-DIGO Advisory Board. Dr Fouque is currently member of the council of ISRNM and ERA-EDTA, and Editor in chief of Nephrol Dial Transplantation journal.
M.D. 1996 School of Medicine - University of Sao Paulo, Sao Paulo, Brazil Residency - Internal Medicine 1999 University of Sao Paulo, Sao Paulo, Brazil Fellowship - Nephrology 2001 University of Sao Paulo, Sao Paulo, Brazil Ph.D. – Nephrology 2006 University of Sao Paulo, Sao Paulo, Brazil M.S.– Clinical Research 2010 University of California San Diego Fellowship – Nephrology 2010 School of Medicine - University of California San Diego
Dr Jeffrey Perl is a staff nephrologist at, St Michael’s Hospital in Toronto and Associate Professor of Medicine at the University of Toronto. He received his Master of Science in Epidemiology from The Harvard School for Public Health. He is a prior recipient of The John Maher Young Investigator Award by the International Society for Peritoneal Dialysis and has received several teaching awards at The University of Toronto and St. Michael’s Hospital. He serves as the current editor-in-chief of Peritoneal Dialysis International. He is also chair of the home dialysis subcommittee of the American Society of Nephrology COVID-19 response team. His primary research interests and clinical practice focuses on improving the survival and quality of life for patients on home dialysis. Dr. Perl is a primary investigator in The International Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) and principal investigator of the Optimizing the Prevention of Peritoneal Dialysis Associated Peritonitis in The United States (OPPUS) study.
Especialista em Nefrologia, com Mestrado em Genética Médica (1990) e Doutorado em Medicina - Nefrologia (2008). Coordenador do Programa de Investigação em Doenças Renais Hereditárias do i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto. Atualmente com foco de pesquisa científica internacional em Doença de Fabry, Síndrome de Alport e Doença Renal Policística Autossômica Dominante.
Dr. Kellum is Professor of Critical Care Medicine, Medicine, Bioengineering and Clinical and Translational Science at the University of Pittsburgh. He is also Chief Medical Officer at Spectral Medical. Dr. Kellum received his medical degree from the Medical College of Ohio in 1984. His postgraduate training includes an internship and residency in Internal Medicine at the University of Rochester, NY, and a Fellowship in Critical Care Medicine at the University of Pittsburgh. His research interests span various aspects of Critical Care Medicine, but center in critical care nephrology, sepsis and multi-organ failure, and clinical epidemiology, including consensus development and research methodology. He has authored more than 700 publications and has won several awards for teaching. He lectures widely and has given more than 400 seminars and invited lectures worldwide related to his research.
Professor Jürgen Floege is head of the Division of Nephrology and Immunology at the University of Aachen, Germany since 1999. He is a former executive council member of the International Society of Nephrology (ISN), the European Renal Association (ERA-EDTA), and KDIGO, a Distinguished Fellow of the ERA-EDTA and recipient of the 2018 ERA-EDTA Award for Outstanding Clinical Contributions to Nephrology. He also is past-president of the German Society of Nephrology and recipient of the 2020 Volhard medal of that society in honor of his life-time achievements. , Together with Professors Richard Johnson, Marcello Tonelli and John Feehally he edits the best-selling textbook “Comprehensive Clinical Nephrology”. Finally, Professor Floege is associate editor of Kidney International since Jan 2018 and currently is a member of the editorial board of JASN, Journal of Nephrology and others. Until 2017 he served as associate editor of NDT. Research interests encompass renal fibrosis, immune-mediated renal disease, in particular IgA-nephropathy, as well as CKD-MBD and cardiovascular disease in uremic patients. His scientific work encompasses more than 600 original papers.
Dr. Salusky is a clinical-translational scientist on the abnormalities of bone and mineral metabolism that are associated with chronic kidney disease (CKD) in children. Over the years, he has aimed to advance our understanding of the mechanisms of disordered mineral metabolism in CKD, including the role of PTH, vitamin D, and FGF23. Through continuous NIH funding, his research group has described the features of bone diseases across the stages of CKD, and after renal transplantation. His group has also provided significant groundwork for elucidating the relationship between abnormalities of bone and mineral metabolism and vascular calcifications in children and young adults treated with dialysis. Moreover, he has defined the effects of therapy with active vitamin D sterols and phosphate binders on the skeletal lesion of secondary hyperparathyroidism. More recently, his group has characterized the role of iron and erythropoietin on FGF23 production in the context of CKD in experimental models and humans.
Dr. Linda Awdishu is a Professor and Division Head of Clinical Pharmacy at University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Awdishu specializes in kidney disease and transplantation. She developed and practices in the Chronic Kidney Disease program at UCSD Health. Her research is focused on the pharmacokinetics of drugs in kidney disease and the pharmacogenomic predictors of drug induced kidney injury.
Nefrologista pela SBN e fellow da ISN.
Epidemiologista, com Master’s in Public Health pela University of Michigan.
Pesquisador do estudo Dialysis Outcomes and Practice Patterns, na empresa Arbor Research Collaborative for Health.
Ann Arbor, EUA.
PhD, MNSc, RN, Specialist in Nephrology Nursing has extensive research expertise in Nephrology Nursing particularly related to those with Acute Kidney Injury and in Renal Conservative Treatment. Maria coordinates de Research Department at the Escola Superior de Enfermagem de Lisboa (ESEL) Portugal where she is presently working as Principal Lecturer. Maria is on the Editorial boards of the Journal Nephro’s in Portugal, integrates the pool of assessors of SciELO for the University of São Paulo, Brazil, Scientific Committee of Enfermeria Nefrologica from SEDEN, Spain as reviewer and (Revista Brasileira de Enfermagem-REBEn as peer reviewer. Maria is responsible for the Masters in Nephrology Nursing at the Escola Superior de Enfermagem de Lisboa, Portugal. Maria has translated several articles, books and handbooks under the Education in Nephrology Care from English to Portuguese As Co Author she published the “EDTNA/ERCA Recommendations for Prevention and Management of Violence and Aggression in renal units”- 2010 As Co Author she published the EDTNA/ERCA “ Competency Framework for Neohrology Nursing” , 2008 As Editor, she published, for EDTNA/ERCA, the handbook: Acute Kidney Injury – a guide to clinical Practice in 2012 She was President of EDTNA/ERCA (European Dialysis and Transplant Nurses Association/European Renal Care Association for 2012-2014 She was Director of Nursing Education for Diaverum from 2014-2016 Principal Lecturer at ESEL – Escola Superior de Enfermagem de Lisboa - Portugal
Martin H. de Borst, MD, PhD is consultant nephrologist at the University Medical Center Groningen, and adjunct professor of medicine at the University of Groningen, The Netherlands. His research focuses on factors driving the progression of chronic kidney disease (CKD) and its cardiovascular complications. He is specifically interested in how deregulation of bone and mineral homeostasis leads to cardiovascular disease in patients with CKD, and whether targeting of fibroblast growth factor 23, vitamin D and klotho can provide cardio-renal benefits. Prof. De Borst has co-authored >200 scientific papers that have been published in leading journals including the New England Journal of Medicine, The Lancet Diabetes, and Nature Genetics, and is co-inventor on two patents. He is Associate Editor of Nephrology, Dialysis and Transplantation (NDT) and Chair of the Young Nephrologists’ Platform of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA).
LIC. ENF. ESP. DIALISIS Y NEFROLOGIA. ESP. GESTION DE LOS SERVICIOS DE SALUD. ESP. NORMA UNIT 9001:2015 ESP. GESTION DE AUDITORIAS INTERNAS Y EXTERNAS. INSPECTORA FISCALIZACION MINISTERIO DE SALUD PUBLICA (URUGUAY). PTE. SOCIEDAD URUGUAYA DE ENFERMERÍA EN NEFROLOGIA (SUEN) PTE. SOCIEDAD LATINOAMERICANA DE ENFERMERIA EN NEFROLOGIA (SLAEN).
Renato C. Monteiro, MD, PhD Renato Monteiro is full professor of Immunology at Paris University and head of the Center for Research on Inflammation – INSERM U1149 & CNRS ERL8252 located at Bichat Hospital campus in Paris. After obtaining his medical degree in Botucatu (UNESP-FMB) Brazil and then completing a residency in nephrology, he moved to Paris in 1982 to study nephrology at the Necker Hospital under the mentoring of Professor Jean Berger. Prof. Monteiro was awarded the 1986 Prize of the French Society of Nephrology for his work on IgA nephropathy, notably for the identification of abnormal IgA in Berger’s disease. He later studied immunology at the University of Birmingham in Alabama with Professor Max Cooper. Prof. Monteiro’s work in Prof. Cooper’s lab led to the identification of the IgA Fc receptor I (CD89). He received his PhD thesis in immunology in 1993 at Paris University. In France, professor Monteiro has made important discoveries in the field of IgA and Fc receptors. His research group identified CD71 transferrin receptor as an IgA1 receptor and pioneered work in involvement of CD89 and CD71 in diseases involving the IgA system such as IgA nephropathy, Henoch-Schönlein purpura, spondylitis, alcoholic cirrhosis, and celiac disease. His team identified an unsuspected function for CD89 and SIGNR1, and beyond, a new role for these molecules as dampers of the immune system. They demonstrated for the first time that FcR-bearing ITAM can have opposite functions depending on the type of ligand (monovalent or multivalent). When occupied by Ig monomers or when targeted by anti-receptor Fab fragment, FcR-bearing ITAM can promote sustained inhibition of cell activation opening new therapeutic approaches. Prof. Monteiro was awarded the 2010 Prize of the French Society of Immunology and of a laboratory of excellence (Inflamex).
Professor titular da Escola de Medicina da Pontifícia Universidade Católica do Paraná e Pesquisador Sênior do Arbor Research Collaborative for Health em Michigan, USA. Líder Científico para estudos clínicos nas Américas pelo George Institute for Global Health. Diretor do comitê de Educação Médica da Sociedade Internacional de Nefrologia (ISN). Foi investigador principal, líder nacional e parte do comitê diretivo de vários estudos clínicos internacionais na área de doenças renais. Foi membro do comitê executivo da ISN (2017-19) e (2015-2018) KDIGO. Em sua carreira publicou mais de 320 artigos científicos, editou um Tratado de Nefrologia e palestrou em cerca de 50 países pelo mundo.
Thomas Nickolas, MD. Dr. Nickolas is an Associate Professor of Medicine at Columbia University Irving Medical Center and a member of the Division of Nephrology. Patients with chronic kidney disease have poor bone strength and increased fracture risk due to older age, excessive inflammation and frailty, and metabolic complications of and medications used to treat kidney disease. Hip and spine fractures are particularly common and can result in an increased morbidity and mortality. His primary interests are in the skeletal effects of kidney disease, focusing on clinical and translational studies of bone cell signaling and bone microarchitecture. The goal of his work is to identify mechanisms that will lay the groundwork for the development and study of novel and effective strategies that will preserve skeletal integrity and prevent bone loss and fractures in patients with kidney disease. His lab uses high resolution in vivo bone imaging to identify how the kidney differentially impacts cortical versus trabecular bone. His group described mechanisms that underly paradoxical observations of increased fracture risk in de novo kidney transplant recipients despite increased or preserved bone mineral density. Recently, his group identified novel circulating markers of bone turnover based on microRNA methods that are highly accurate for the non-invasive diagnosis of renal osteodystrophy type. Further development of these findings is critically relevant to the diagnosis, treatment and monitoring of kidney related bone disease.